66 related articles for article (PubMed ID: 8067719)
21. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.
Arango D; Corner GA; Wadler S; Catalano PJ; Augenlicht LH
Cancer Res; 2001 Jun; 61(12):4910-5. PubMed ID: 11406570
[TBL] [Abstract][Full Text] [Related]
22. [The significance of p53 gene mutations and expressions in human colorectal tumors].
Qian H; Yu B; Zhou X
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):332-5. PubMed ID: 8697968
[TBL] [Abstract][Full Text] [Related]
23. [Expression of p53 and bcl-2 in colorectal adenomas and carcinomas].
Sundblad AS; Chumbita RL; Zoppi JA
Medicina (B Aires); 1997; 57(6):662-6. PubMed ID: 9674186
[TBL] [Abstract][Full Text] [Related]
24. p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder.
Kamel D; Pääkkö P; Nuorva K; Vähäkangas K; Soini Y
J Pathol; 1993 May; 170(1):67-72. PubMed ID: 8100854
[TBL] [Abstract][Full Text] [Related]
25. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
Gudas JM; Klein RC; Oka M; Cowan KH
Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
[TBL] [Abstract][Full Text] [Related]
26. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
27. Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients.
Swellam M; Ismail M; Eissa S; Hamdy M; Mokhtar N
IUBMB Life; 2004 Aug; 56(8):483-90. PubMed ID: 15545228
[TBL] [Abstract][Full Text] [Related]
28. Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell lines.
Thompson MA; Flegg R; Westin EH; Ramsay RG
Oncogene; 1997 Apr; 14(14):1715-23. PubMed ID: 9135073
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas.
Islam HK; Fujioka Y; Tomidokoro T; Sugiura H; Takahashi T; Kondo S; Katoh H
Hepatogastroenterology; 2001; 48(39):879-83. PubMed ID: 11462947
[TBL] [Abstract][Full Text] [Related]
30. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters.
Sirotkovic-Skerlev M; Krizanac S; Kapitanovic S; Husnjak K; Unusic J; Pavelic K
Exp Mol Pathol; 2005 Aug; 79(1):42-50. PubMed ID: 16005711
[TBL] [Abstract][Full Text] [Related]
31. c-myc Gene amplification in primary stomach cancer.
Koda T; Matsushima S; Sasaki A; Danjo Y; Kakinuma M
Jpn J Cancer Res; 1985 Jul; 76(7):551-4. PubMed ID: 2993214
[TBL] [Abstract][Full Text] [Related]
32. Expression of p53 upregulated modulator of apoptosis (PUMA) and C-myb in gallbladder adenocarcinoma and their pathological significance.
Cai W; Li Q; Yang Z; Miao X; Wen Y; Huang S; Ouyang J
Clin Transl Oncol; 2013 Oct; 15(10):818-24. PubMed ID: 23475628
[TBL] [Abstract][Full Text] [Related]
33. Nuclear oncogene amplification or rearrangement is not involved in human colorectal malignancies.
Dolcetti R; De Re V; Viel A; Pistello M; Tavian M; Boiocchi M
Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1321-8. PubMed ID: 3181252
[TBL] [Abstract][Full Text] [Related]
34. [An attempt at using monoclonal antibodies to oncogene products].
Kuzumaki N
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2205-11. PubMed ID: 3300558
[TBL] [Abstract][Full Text] [Related]
35. Mapping of amplified c-myb oncogene, sister chromatid exchanges, and karyotypic analysis of the COLO 205 colon carcinoma cell line.
Winqvist R; Knuutila S; Leprince D; Stehelin D; Alitalo K
Cancer Genet Cytogenet; 1985 Nov; 18(3):251-64. PubMed ID: 3863699
[TBL] [Abstract][Full Text] [Related]
36. A unique pattern of proto-oncogene abnormalities in ovarian adenocarcinomas.
Zhou DJ; Gonzalez-Cadavid N; Ahuja H; Battifora H; Moore GE; Cline MJ
Cancer; 1988 Oct; 62(8):1573-6. PubMed ID: 3167770
[TBL] [Abstract][Full Text] [Related]
37. ["Cancer family syndrome"--description of a family with a hereditary incidence of malignant tumors of the colon and other organs].
Hasselgren PO; Hultén L; Karlström L
Lakartidningen; 1984 Jun; 81(24):2451-3. PubMed ID: 6738248
[No Abstract] [Full Text] [Related]
38. Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma.
Alitalo K; Winqvist R; Lin CC; de la Chapelle A; Schwab M; Bishop JM
Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4534-8. PubMed ID: 6589609
[TBL] [Abstract][Full Text] [Related]
39. Chromosomal localization of amplified c-myc in a human colon adenocarcinoma cell line with a biotinylated probe.
Cherif D; Le Coniat M; Suarez HG; Bernheim A; Berger R
Cancer Genet Cytogenet; 1988 Jul; 33(2):245-9. PubMed ID: 3164247
[TBL] [Abstract][Full Text] [Related]
40. Presence of circulating anti-c-myb oncogene product antibodies in human sera.
Sorokine I; Ben-Mahrez K; Bracone A; Thierry D; Ishii S; Imamoto F; Kohiyama M
Int J Cancer; 1991 Mar; 47(5):665-9. PubMed ID: 2004847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
